| Abby L Vrable, | |
|
8060 Market St, Youngstown, OH 44512-6241 | |
| (330) 758-9189 | |
| Not Available |
| Full Name | Abby L Vrable |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 8 Years |
| Location | 8060 Market St, Youngstown, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285098491 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 34.014891 (Ohio) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dr Jenifer R Lloyd Llc | 2668668278 | 3 |
News Archive
An extensive study of country-specific risk of hip fracture and 10-year probability of a major fragility fracture has revealed a remarkably large geographic variation in fracture risk. Even accounting for possible errors or limitations in the source data, there was an astonishing 10-fold variation in hip fracture risk and fracture probability between countries.
The Ensign Group, Inc. announced today that its Board of Directors has declared a quarterly cash dividend of $0.05 per share of Ensign common stock, which is an increase from the prior quarterly cash dividend of $0.045 per share.
Physician-scientists at Memorial Sloan-Kettering Cancer Center are studying a novel approach to treat metastatic melanoma, known as immunotherapy, which uses the body's own immune system to attack cancer. Presented today at the American Society of Clinical Oncology annual meeting, encouraging new data shows - for the first time - a survival benefit in metastatic melanoma patients using an immunotherapy discovered and clinically investigated by researchers at Memorial Sloan-Kettering.
Type-1 diabetes occurs when immune cells attack the pancreas. EPFL scientists have now discovered what may trigger this attack, opening new directions for treatments.
› Verified 1 days ago
| Entity Name | Dr Jenifer R Lloyd Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629385737 PECOS PAC ID: 2668668278 Enrollment ID: O20101122000881 |
News Archive
An extensive study of country-specific risk of hip fracture and 10-year probability of a major fragility fracture has revealed a remarkably large geographic variation in fracture risk. Even accounting for possible errors or limitations in the source data, there was an astonishing 10-fold variation in hip fracture risk and fracture probability between countries.
The Ensign Group, Inc. announced today that its Board of Directors has declared a quarterly cash dividend of $0.05 per share of Ensign common stock, which is an increase from the prior quarterly cash dividend of $0.045 per share.
Physician-scientists at Memorial Sloan-Kettering Cancer Center are studying a novel approach to treat metastatic melanoma, known as immunotherapy, which uses the body's own immune system to attack cancer. Presented today at the American Society of Clinical Oncology annual meeting, encouraging new data shows - for the first time - a survival benefit in metastatic melanoma patients using an immunotherapy discovered and clinically investigated by researchers at Memorial Sloan-Kettering.
Type-1 diabetes occurs when immune cells attack the pancreas. EPFL scientists have now discovered what may trigger this attack, opening new directions for treatments.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Abby L Vrable, 8060 Market St, Youngstown, OH 44512-6241 Ph: () - | Abby L Vrable, 8060 Market St, Youngstown, OH 44512-6241 Ph: (330) 758-9189 |
News Archive
An extensive study of country-specific risk of hip fracture and 10-year probability of a major fragility fracture has revealed a remarkably large geographic variation in fracture risk. Even accounting for possible errors or limitations in the source data, there was an astonishing 10-fold variation in hip fracture risk and fracture probability between countries.
The Ensign Group, Inc. announced today that its Board of Directors has declared a quarterly cash dividend of $0.05 per share of Ensign common stock, which is an increase from the prior quarterly cash dividend of $0.045 per share.
Physician-scientists at Memorial Sloan-Kettering Cancer Center are studying a novel approach to treat metastatic melanoma, known as immunotherapy, which uses the body's own immune system to attack cancer. Presented today at the American Society of Clinical Oncology annual meeting, encouraging new data shows - for the first time - a survival benefit in metastatic melanoma patients using an immunotherapy discovered and clinically investigated by researchers at Memorial Sloan-Kettering.
Type-1 diabetes occurs when immune cells attack the pancreas. EPFL scientists have now discovered what may trigger this attack, opening new directions for treatments.
› Verified 1 days ago
Dr. Madeline Mcneil Tarrillion, D.O. Dermatology Medicare: Medicare Enrolled Practice Location: 8060 Market St, Youngstown, OH 44512 Phone: 330-758-9189 Fax: 330-758-4487 | |
Dr. Susan G Woods, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 20 Ohltown Rd, Youngstown, OH 44515 Phone: 330-884-1557 Fax: 330-799-0261 | |
Sayeeda Ahsanuddin, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 500 Gypsy Ln, Youngstown, OH 44504 Phone: 330-884-3573 | |
Dr. Chi Sown Ko, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 3132 Belmont Ave, Youngstown, OH 44505 Phone: 330-759-0644 Fax: 330-759-1893 | |
Dr. Jenifer R Lloyd, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 8060 Market St, Youngstown, OH 44512 Phone: 330-758-9189 Fax: 330-758-4487 | |
Anthony L Mehle, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 960 Windham Ct, Ste 2, Youngstown, OH 44512 Phone: 330-758-8866 Fax: 330-758-4051 |